Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00150787
Status:
COMPLETED
Last Update Posted:
2013-11-26
First Post:
2005-09-06
Brief Title:
Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy
Sponsor:
UCB Pharma
Organization:
UCB Pharma
Study Overview
Official Title:
A Multicenter Double-blind Follow-up Trial Evaluating the Long-term Safety of Levetiracetam 1000 to 3000 mgDay Oral bid and Carbamazepine 400 to 1200 mgDay Oral bid Used as Monotherapy in Subjects 16 Years Coming From the N01061 Trial
Status:
COMPLETED
Status Verified Date:
2009-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A double-blind follow-up trial assessing the long term safety of Levetiracetam as per adverse events reporting physical and neurological examination and vital signs
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None